Grant: Discovery Grants Program - Individual
McGill University
$34,000.00
Structural studies of Baeyer-Villiger monooxygenases
FY 2014-15
Summary
Drugs are complex molecules that have very specific shapes. Pharmaceutical industry has been making these drugs using chemical reactions that frequently use toxic solvents and invariably create substantial waste. To address these issues that have environmental and financial implications, ""green-chemistry"" alternatives have been explored. One such alternative, is the use of ""biocatalysts"", i.e. enzymes that catalyze chemical reactions without the use of toxic solvents and that do not create excessive waste. Specifically, much attention has focused on ""Baeyer-Villiger monooxygenases"". Baeyer-Villiger monooxygenases are a class of enzymes found in bacteria that catalyze a type of reaction that is commonplace in the pharmaceutical industry. Employing these enzymes in an industrial setting will avoid the use of chlorinated solvents and acids, while limiting the amount of waste product produced. We have recently determined what these enzymes look like in atomic detail, using a method known as X-ray diffraction. Also, we have begun to examine how the atomic structure of these enzymes dictates their catalytic properties. Intriguingly, our initial studies have shown that the shape of the enzymes actually changes while they catalyze chemical reactions. We will continue to examine in atomic detail how Baeyer-Villiger monooxygenases catalyze chemical reactions, and how the changing shape facilitates this. This information will enable us to optimize these enzymes for very specific tasks that are of benefit to the pharmaceutical industry.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
183867-2013
Name nom
Berghuis, Albert
Department département
Biochemistry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2013
Award amount
34000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
5404
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Enzymes
Research subject fr
Enzymes
Partie
2
Nb partie
5
Application title
Structural studies of Baeyer-Villiger monooxygenases
Keyword
NSERC
Application summary
Drugs are complex molecules that have very specific shapes. Pharmaceutical industry has been making these drugs using chemical reactions that frequently use toxic solvents and invariably create substantial waste. To address these issues that have environmental and financial implications, ""green-chemistry"" alternatives have been explored. One such alternative, is the use of ""biocatalysts"", i.e. enzymes that catalyze chemical reactions without the use of toxic solvents and that do not create excessive waste. Specifically, much attention has focused on ""Baeyer-Villiger monooxygenases"". Baeyer-Villiger monooxygenases are a class of enzymes found in bacteria that catalyze a type of reaction that is commonplace in the pharmaceutical industry. Employing these enzymes in an industrial setting will avoid the use of chlorinated solvents and acids, while limiting the amount of waste product produced. We have recently determined what these enzymes look like in atomic detail, using a method known as X-ray diffraction. Also, we have begun to examine how the atomic structure of these enzymes dictates their catalytic properties. Intriguingly, our initial studies have shown that the shape of the enzymes actually changes while they catalyze chemical reactions. We will continue to examine in atomic detail how Baeyer-Villiger monooxygenases catalyze chemical reactions, and how the changing shape facilitates this. This information will enable us to optimize these enzymes for very specific tasks that are of benefit to the pharmaceutical industry.